​
Login / Signup
Ralph R Reid
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Top Topics
Cancer Therapy
Oxidative Stress
Dna Damage Response
Top Venues
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Shaun D Fontaine
,
Christopher W Carreras
,
Ralph R Reid
,
Gary W Ashley
,
Daniel V Santi
A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors.
Cancer research communications
3 (5) (2023)
Shaun D Fontaine
,
Christopher W Carreras
,
Ralph R Reid
,
Gary W Ashley
,
Daniel V Santi
A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors.
Cancer research communications
3 (5) (2023)
Shaun D Fontaine
,
Christopher W Carreras
,
Ralph R Reid
,
Gary W Ashley
,
Daniel V Santi
A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors.
Cancer research communications
3 (5) (2023)
Shaun D Fontaine
,
Christopher W Carreras
,
Ralph R Reid
,
Gary W Ashley
,
Daniel V Santi
A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors.
Cancer research communications
3 (5) (2023)
Shaun D Fontaine
,
Christopher W Carreras
,
Ralph R Reid
,
Gary W Ashley
,
Daniel V Santi
A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors.
Cancer research communications
3 (5) (2023)